Krystal Biotech (KRYS) Gross Margin (2023 - 2025)
Historic Gross Margin for Krystal Biotech (KRYS) over the last 3 years, with Q4 2025 value amounting to 93.85%.
- Krystal Biotech's Gross Margin fell 7200.0% to 93.85% in Q4 2025 from the same period last year, while for Dec 2025 it was 94.08%, marking a year-over-year increase of 9800.0%. This contributed to the annual value of 94.08% for FY2025, which is 9800.0% up from last year.
- As of Q4 2025, Krystal Biotech's Gross Margin stood at 93.85%, which was down 7200.0% from 95.64% recorded in Q3 2025.
- In the past 5 years, Krystal Biotech's Gross Margin registered a high of 97.39% during Q3 2023, and its lowest value of 91.45% during Q2 2024.
- In the last 3 years, Krystal Biotech's Gross Margin had a median value of 94.07% in 2025 and averaged 93.96%.
- Its Gross Margin has fluctuated over the past 5 years, first tumbled by -53700bps in 2024, then skyrocketed by 36100bps in 2025.
- Quarter analysis of 3 years shows Krystal Biotech's Gross Margin stood at 93.19% in 2023, then rose by 1bps to 94.57% in 2024, then fell by -1bps to 93.85% in 2025.
- Its Gross Margin stands at 93.85% for Q4 2025, versus 95.64% for Q3 2025 and 92.54% for Q2 2025.